Physician

Ronald L Schwartz, MD

According to 2025 Medicare claims, Ronald Schwartz, MD (NPI: 1780793331) practices neurology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39401-7246. Schwartz is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Schwartz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,379 traditional Medicare patients, billed 473,229 HCPCS/CPT codes, and received $2,907,472 in Medicare payments. The top billing code was A9586 (Florbetapir f18, diagnostic, per study dose, up to 10 millicuries). Part D data shows 7,343 prescription claims across 1,313 beneficiaries totaling $634,299 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). Open Payments data shows 203 records totaling $715,480. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $551,766 to $2,907,472. In contrast, Part D prescription costs have declined steadily, from $1,196,712 to $634,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,213	7,550	$551,766
2016	1,195	8,776	$546,980
2017	1,209	8,926	$544,230
2018	1,267	8,831	$593,916
2019	1,237	9,654	$776,116
2020	1,031	9,046	$553,845
2021	959	9,025	$456,144
2022	1,023	12,457	$536,766
2023	1,147	72,743	$791,173
2024	1,379	473,229	$2,907,472

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	684	7,582	$1,196,712
2016	768	8,177	$1,018,904
2017	817	8,586	$1,058,875
2018	883	8,673	$1,027,528
2019	951	7,871	$927,237
2020	896	5,695	$669,949
2021	904	5,057	$674,751
2022	949	4,662	$608,159
2023	1,153	6,431	$577,925
2024	1,313	7,343	$634,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
A9586	Florbetapir f18, diagnostic, per study dose, up to 10 millicuries	332	332	$2,370
78814	Nuclear medicine study limited area with ct scan	325	325	$1,085
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	484	541	$55
96138	Administration of psychological or neuropsychological test by technician, first 30 minutes	283	284	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	649	758	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	32	672	$285,369
Nuedexta	Dextromethorphan Hbr/Quinidine	45	1,350	$54,678
Memantine Hcl	Memantine Hcl	1,994	124,450	$51,734
Rivastigmine	Rivastigmine	126	5,940	$23,619
Rexulti	Brexpiprazole	16	494	$21,078

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	166	$114,745	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	37	$600,735	Biogen, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald L. Schwartz, MD?

Tedicare shows public-source Medicare data for Ronald L. Schwartz, MD (NPI 1780793331), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald L. Schwartz, MD have ACO affiliation data?

Ronald L. Schwartz, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to Ronald L. Schwartz, MD?

Ronald L. Schwartz, MD is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Ronald L. Schwartz, MD have Open Payments data?

Ronald L. Schwartz, MD has 203 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.